Videos

Erin Carey, MD, tackles the different methods for pain management in endometriosis during her presentation at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting.

In this EdTalk, presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting, Lisa Foglia, MD; Andrea L. Braden, MD; and Catherine Cansino, MD, MPH, discuss strategies for improving diversity and equity within obstetrics and gynecology.

Immediate past president Eva Chalas, MD, discusses the top sessions, events and presentations to watch for at ACOG's annual meeting.

Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.

Drs Jessica A. Shepherd and Mauricio Abrão share recommendations for the treatment selection of GnRH antagonists when treating patients with uterine fibroids.

Jessica A. Shepherd, MD, MBA, FACOG, and Mauricio Abrão, MD, assess the use of FDA-approved GnRH antagonists in clinical practice.

Elizabeth Ruzzo, PhD, discusses the findings of a report published by the UNFPA, which found women were abandoning effective methods of contraception due to misinformation.

Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss individualizing treatment decisions in girls with central precocious puberty (CPP).

Experts in gynecology provide an overview of GnRH antagonists and examine the therapeutic use of these agents in treating patients with uterine fibroids.

Drs Mauricio Abrão and Jessica A. Shepherd provide insight on treating fibroids with nonsurgical treatment options for patients.

An expert reproductive endocrinologist explores the future treatment landscape for patients with endometriosis.

Hugh Taylor, MD, provides insight on remaining gaps in care in the endometriosis treatment landscape.

Dr Hugh Taylor discusses his treatment approach for patients with presumed endometriosis.

An expert in reproductive endocrinology reviews endometriosis treatment options for various patient populations, including patients with infertility, endometriomas, deep endometriosis, and effects on nonreproductive organs.

Dr Robert N. Taylor provides insight on emerging treatments and integrative therapies on the horizon with elagolix as well as real-world challenges using elagolix for endometriosis management.

Robert N. Taylor, MD, PhD, discusses key findings from clinical trial data on the dosing, pain relief profile, and adverse events of elagolix for patients with endometriosis.

An expert reproductive endocrinologist comments on the patient selection of aromatase inhibitors and the role of selective estrogen receptor modulators (SERMs) for endometriosis treatment.

Dr Robert N. Taylor examines the use of GnRH receptor antagonists, including elagolix, for the management of endometriosis.

Robert N. Taylor, MD, PhD, reviews first- and second-line therapies for the treatment of endometriosis.

An expert in reproductive endocrinology comments on the impact of endometriosis on a patient’s quality of life.

Dr Hugh Taylor highlights the importance of early detection of disease and the use of imaging technology in the diagnosis of endometriosis.

Hugh Taylor, MD, differentiates endometriosis from other disorders causing pelvic pain and shares common risk factors for the disease.

Dr Mauricio Abrão leads a discussion on considerations for selecting the optimal surgical options for patients with uterine fibroids.

Experts in gynecology discuss factors to consider when approaching the treatment of patients with uterine fibroids and discuss the importance of shared decision-making.

Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, comment on the use of diagnostic tools and the importance of imaging in approaching the treatment of uterine fibroids.

Mauricio Abrão, MD, provides an overview of the diagnosis, risk factors, and clinical burden of uterine fibroids.

Pathology expert Mark H. Stoler, MD, discussed the BD Onclarity™ HPV Assay for primary HPV screening and what it means for the future of cervical cancer detection.

Burnout is uniquely pervasive in medicine, regardless of specialty, making physicians more susceptible than the average person. Matthew T. Siedhoff, MD, MSCR, discusses warning signs to watch for and shares his habit-hacking tips to refocus your routines and bring wellness back into your life.

Greg Marchand, MD, talks about his recently published article evaluating the underused potential of combined laparoscopic salpingectomy and endometrial ablation for treatment of abnormal uterine bleeding and desired sterilization.

Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.